ckd-581
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2012 (NCT01580371)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Histone deacetylase 2INHIBITOR
HDAC2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ckd-581
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03150316 | Phase 1 | May 10, 2017 | Catholic University of Korea, Chong Kun Dang Pharmaceutical |
| NCT03051841 | Phase 1 | Jan 1, 2017 | Chong Kun Dang Pharmaceutical |
| NCT01580371 | Phase 1 | May 1, 2012 | Chong Kun Dang Pharmaceutical |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chong Kun Dang Pharmaceutical | For profit | 3 | 3 | 1 | 2012 |
| Catholic University of Korea | Academic/Hospital | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1